Remimazolam for sedation in elderly patients undergoing gastrointestinal endoscopy: Protocol for a scoping review

Background Gastrointestinal (GI) endoscopy is one of the most commonly performed procedures in older adults, who constitute an increasing proportion of the endoscopic population yet face a higher risk of sedation-related cardiorespiratory adverse events, delayed recovery, and postoperative neurocognitive disturbances. Remimazolam, an ultra-short-acting benzodiazepine metabolised by tissue esterases independently of hepatic and renal function, is a candidate sedative of particular interest in this group. However, the extent and gaps of the available evidence specific to sedation with remimazolam in elderly patients undergoing GI endoscopy have not been systematically mapped. Objectives To systematically map the existing evidence on the use of remimazolam for procedural sedation in elderly patients (aged ≥65 years) undergoing GI endoscopy, characterising study design, reported outcomes, comparators, and dosing regimens, and identifying knowledge gaps. Methods This scoping review will be conducted in accordance with the JBI methodology for scoping reviews and reported following the PRISMA extension for Scoping Reviews (PRISMA-ScR). We will search PubMed, Embase, the Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, and Scopus, together with the Chinese databases CNKI, Wanfang, and VIP (CQVIP), from 1 January 2015 to the search date—a start date that precedes the earliest published clinical reports of remimazolam. Google Scholar will be used as a supplementary source for grey literature and additional records. The search will be further supplemented by trial registries (ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform[ICTRP], and the Chinese Clinical Trial Registry[ChiCTR]), citation chasing, and additional grey literature. Eligibility will be limited to reports published in English or Chinese, reflecting the substantial body of relevant Chinese-language literature. Two reviewers will independently screen records and extract data using a piloted extraction form. Results will be presented in tabular and diagrammatic form alongside a narrative synthesis and an evidence map. Expected results and dissemination This scoping review is expected to map the current extent, range, and nature of evidence on remimazolam for sedation in elderly patients undergoing gastrointestinal endoscopy, will map the volume, designs and outcomes of existing studies and, by visualising this evidence, identify gaps to inform trial design in this high-risk population. The findings will be disseminated through publication in a peer-reviewed journal and presentation at relevant academic conferences.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-11-19
DOI
https://doi.org/10.1371/journal.pone.0363250
Primary Topic
Anesthesia and Sedative Agents
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Remimazolam for sedation in elderly patients undergoing gastrointestinal endoscopy: Protocol for a scoping review

Hong Zhang, Xuejun Li, zhongyuan zhou, Shuang Tao
3 links
PLoS ONE
Anesthesia and Sedative Agents
article

Remimazolam for sedation in elderly patients undergoing gastrointestinal endoscopy: Protocol for a scoping review

Hong Zhang, Xuejun Li, zhongyuan zhou, Shuang Tao
article en

Abstract

Background Gastrointestinal (GI) endoscopy is one of the most commonly performed procedures in older adults, who constitute an increasing proportion of the endoscopic population yet face a higher risk of sedation-related cardiorespiratory adverse events, delayed recovery, and postoperative neurocognitive disturbances. Remimazolam, an ultra-short-acting benzodiazepine metabolised by tissue esterases independently of hepatic and renal function, is a candidate sedative of particular interest in this group. However, the extent and gaps of the available evidence specific to sedation with remimazolam in elderly patients undergoing GI endoscopy have not been systematically mapped. Objectives To systematically map the existing evidence on the use of remimazolam for procedural sedation in elderly patients (aged ≥65 years) undergoing GI endoscopy, characterising study design, reported outcomes, comparators, and dosing regimens, and identifying knowledge gaps. Methods This scoping review will be conducted in accordance with the JBI methodology for scoping reviews and reported following the PRISMA extension for Scoping Reviews (PRISMA-ScR). We will search PubMed, Embase, the Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, and Scopus, together with the Chinese databases CNKI, Wanfang, and VIP (CQVIP), from 1 January 2015 to the search date—a start date that precedes the earliest published clinical reports of remimazolam. Google Scholar will be used as a supplementary source for grey literature and additional records. The search will be further supplemented by trial registries (ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform[ICTRP], and the Chinese Clinical Trial Registry[ChiCTR]), citation chasing, and additional grey literature. Eligibility will be limited to reports published in English or Chinese, reflecting the substantial body of relevant Chinese-language literature. Two reviewers will independently screen records and extract data using a piloted extraction form. Results will be presented in tabular and diagrammatic form alongside a narrative synthesis and an evidence map. Expected results and dissemination This scoping review is expected to map the current extent, range, and nature of evidence on remimazolam for sedation in elderly patients undergoing gastrointestinal endoscopy, will map the volume, designs and outcomes of existing studies and, by visualising this evidence, identify gaps to inform trial design in this high-risk population. The findings will be disseminated through publication in a peer-reviewed journal and presentation at relevant academic conferences.

PLoS ONEVol. 21(11)
The Affiliated Shunde Hospital of Jinan University (CN)
Good health and well-being
Anesthesia and Sedative Agents
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon